Shanghai Securities News China Securities Network News (reporter Confucius Ziyuan) Jichuan Pharmaceutical announced that Jichuan Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, received the "Drug Registration Certificate" of the concentrated solution of magnesium sodium sodium sulfate and potassium oral administration approved by the State Food and Drug Administration. As a new type of intestinal cleansing preparation agent, the drug has the characteristics of small dosage, high patient tolerance and good intestinal cleansing effect, which is not only suitable for intestinal cleansing preparation before colonoscopy, but also for intestinal cleansing preparation before surgery and radiation examination. At present, the company's magnesium sodium sulfate sodium potassium mouth to take concentrated solution for the domestic imitation listing. In addition to the company, no other manufacturers have been approved for listing in the Chinese mainland.
![These vitamins, eye drops, and pediatric cough syrup were written off! Come and see if your house has it?[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)